NLRP4 | NLR family, pyrin domain containing 4 | | | | | | Group enriched |
SPATC1 | Spermatogenesis and centriole associated 1 | | | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AC018867.2 | | Predicted membrane proteins
| | | | | Group enriched |
ANKRD18A | Ankyrin repeat domain 18A | | | | | | Group enriched |
CEACAM4 | Carcinoembryonic antigen-related cell adhesion molecule 4 | Predicted membrane proteins
| | | | | Group enriched |
CHST13 | Carbohydrate (chondroitin 4) sulfotransferase 13 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CXCL9 | Chemokine (C-X-C motif) ligand 9 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXXC11 | CXXC finger protein 11 | Predicted membrane proteins
| | | | | Group enriched |
FAM178B | Family with sequence similarity 178, member B | | | | | | Group enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
IL21 | Interleukin 21 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
IL34 | Interleukin 34 | Predicted secreted proteins
| | | | | Group enriched |
ITGAD | Integrin, alpha D | CD markers Predicted membrane proteins
| | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TLR10 | Toll-like receptor 10 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TRAPPC3L | Trafficking protein particle complex 3-like | | | | | | Group enriched |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Group enriched |
BAI1 | Brain-specific angiogenesis inhibitor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted membrane proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CHODL | Chondrolectin | Predicted membrane proteins
| | | | | Group enriched |
CLEC5A | C-type lectin domain family 5, member A | Predicted membrane proteins
| | | | | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
DNAH10 | Dynein, axonemal, heavy chain 10 | | | | | | Group enriched |
FAM159A | Family with sequence similarity 159, member A | Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GPR88 | G protein-coupled receptor 88 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
L1TD1 | LINE-1 type transposase domain containing 1 | | | | | | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | | | | Group enriched |
MMP25 | Matrix metallopeptidase 25 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Transcription factors
| | | | | Group enriched |
NTNG2 | Netrin G2 | Predicted secreted proteins
| | | | | Group enriched |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIGLEC11 | Sialic acid binding Ig-like lectin 11 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIT1 | Signaling threshold regulating transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Group enriched |
TCTEX1D1 | Tctex1 domain containing 1 | | | | | | Group enriched |